VIOLETA SERRA

This user account status is Approved

This user has not added any information to their profile yet.

VIOLETA
SERRA
+34 93 2746766
Vall d'Hebron Institute of Oncology - Barcelona
2014
Studying early molecular responses following PI3K inhibition to rationally design novel combination therapy in breast cancer. Developing predictive and pharmacodynamic biomarkers of PI3K-pathway inhibitors.•Unveiling novel mechanisms of resistance against targeted therapies in germline BRCA1/2 breast cancer.
Establishing a patient tumor-derived breast cancer preclinical model to explore hypothesis-based combinatorial therapies.